Comments
FDC has received an Establishment Inspection Report for its manufacturing facility located at MIDC Industrial Area, Waluj, Aurangabad, Maharashtra. Earlier, the USFDA had inspected the unit from August 10, 2018 to August 16, 2018. The company was issued Form 483 by the US FDA containing eight observations. The facility is considered to be acceptable with regard to current Good Manufacturing Practices (GMPs) and the inspection stands closed, FDC informed the exchanges on Wednesday. Shares of FDC ended flat at ₹201.90 on the BSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.